Agenzia Italiana del Farmaco
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 October 2025 - Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 October 2025
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 October 2025
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) – 27-30 October 2025:
Injectable tranexamic acid
- Safety issue: Cases of medication errors have been reviewed in which tranexamic acid was mistakenly administered intrathecally or epidurally, due to confusion with other medications, particularly local anesthetics. Patients experienced serious adverse reactions, including severe pain localized to the back, buttocks, and lower limbs, seizures, cardiac arrhythmias, and, in some cases, death.
- Communications/Recommendations: The PRAC recommends to disseminate Direct Healthcare Professionals Communication (DHPC) about the use of injectable tranexamic acid in order to prevent such errors, reminding that the medicine should only be administered intravenously. The PRAC also recommends to clearly label syringes with the words "for intravenous use only" and storing tranexamic acid separately from local anaesthetics.
Published on: 31 October 2025
📢 Via libera dal CdA di #AIFA alla rimborsabilità di 4 nuovi #farmaci, tra cui un medicinale orfano...
Vai al post →
Quando si parla di #antibiotici, le nostre scelte possono avere conseguenze che vanno oltre la #salu...
Vai al post →
👉 Un antibiotico che ha funzionato in passato non è necessariamente quello giusto per una nuova inf...
Vai al post →
💊 Gli #antibiotici sono alleati preziosi per la nostra #salute, ma utilizzarli quando non serve può...
Vai al post →
Tumore del pancreas: AIFA già al lavoro sul daraxonrasib per garantire accesso equo e tempestivo.
D...
Vai al post →
📅 18 novembre
Oggi si celebra la Giornata europea degli #antibiotici (European Antibiotic Awareness...
Vai al post →
